• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Financial Services·8223.HK
Share

Ziyuanyuan Holdings Group Limited Stocks

HK$ 0.15Last Updated 16.10.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

HK$ 12.17M

HK$ 0.15
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Ziyuanyuan Holdings Group Limited, an investment holding enterprise, primarily offers medical equipment finance leasing services across the People's Republic of China. The company's business activities are structured into distinct segments: Finance Leasing, Postpartum Care Services, and the Trade of Medical Equipment and Consumables. Within its finance leasing division, it extends both sale-leaseback and direct financing options, specifically targeting medium, small, and micro-sized businesses across diverse sectors such as printing, logistics, and transportation. Furthermore, Ziyuanyuan provides specialized care for mothers and infants post-delivery, alongside technological support and money lending facilities. Founded in 2014, the firm's main office is located in Shenzhen, PRC, functioning as a subsidiary of Hero Global Limited.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is neutral on EV/EBITDA, overpriced on P/FC.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

19.10.2026 21:11

"Not all Neoclouds are the same": Experts recommend buying CoreWeave and Nebius after the market correction

19.10.2026 20:13

Silence Therapeutics soars 125% as Merck to acquire developer of blood cancer drug

19.10.2026 18:43

"A buying opportunity is emerging": Nasdaq jumped 1% after the sell-off

19.10.2026 18:30

Analysts see 35% upside in label maker Brady on data center demand and Honeywell deal

19.10.2026 18:09

Goldman names 23 'unloved' defensive stocks as tech falters

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026